HDAC9 and prostate carcinoma: Inhibition of HDAC in human prostate cancer cell lines using suberoylanilide hydroxamic acid (SAHA).Inhibition of HDAC in radioresistant esophageal carcinoma cells lines using trichostatin A and sodium butyrate.